TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
GOSS

Gossamer Bio Inc

Healthcare · Biotechnology

10.90$ +0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Gossamer Bio Inc (GOSS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 77 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GOSS
Line item Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
0.1 – – – 0.4 55 55 262 239 516 507 470 427 371 625 584 539 482 433 387 344 295 246 324 272 220 182 348 312 259 373 351 315 281 241 209 172 129 77
– – – – 0.4 0.3 53 258 232 498 490 452 409 355 608 566 522 466 417 374 332 281 233 312 262 210 173 341 307 255 371 344 310 275 236 204 168 125 73
0.1 – – – 0.3 -0.3 32 141 105 171 149 131 135 111 486 462 486 440 342 213 183 139 94 153 112 65 37 83 32 39 87 28 46 29 26 8.9 38 41 41
– – – – 0.3 0.3 52 256 229 481 464 446 402 346 600 555 513 453 406 366 325 272 222 304 256 202 162 329 296 244 354 327 295 258 213 180 137 99 57
– – – – – – – – – – – – 1.5 1.3 0.6 0.5 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 – – 0.1 – – – 3.6 6.6 5.3 6.6 8.0 9.6 13 9.4 6.1
– – – – – – – – – – – – – – – – – 0.4 0.5 -0.1 -0.1 -0.1 -0.2 -0.1 – – -0.1 – – – – – – – – – – – –
– – – – – 1.4 1.4 3.0 3.2 16 16 16 16 15 16 5.7 5.5 5.9 14 5.6 5.3 5.0 4.7 4.3 4.0 3.5 3.1 – – – – – – – – – – – –
0.2 – – – 7.3 6.7 6.2 16 359 36 66 71 74 65 205 212 219 210 212 217 222 265 262 267 260 248 245 243 249 233 292 297 286 287 287 291 295 290 171
0.1 – – – 1.3 6.2 6.2 15 20 25 28 33 37 28 28 33 39 29 30 36 40 35 44 53 49 41 40 42 52 36 45 51 45 48 54 62 63 57 138
– – – – – – – – – 2.2 2.2 2.3 2.4 2.4 3.2 3.5 3.6 3.5 3.4 3.0 2.9 2.8 14 15 15 15 15 15 15 12 1.8 1.7 1.0 0.9 0.9 0.9 0.9 1.0 36
0.0 – – – 0.1 0.9 0.9 3.6 2.2 4.5 3.0 2.6 1.0 2.6 0.2 0.9 7.5 1.1 0.9 1.2 3.2 0.6 3.9 0.4 1.5 2.7 2.2 1.3 5.5 2.7 1.0 3.1 2.3 3.4 1.9 1.1 6.0 11 6.0
0.0 – – – 6.0 – – – – 11 28 28 28 29 169 29 172 29 176 29 179 29 213 210 208 205 203 200 197 197 197 197 198 198 198 198 199 199 –
– – – – -6.9 -6.9 48 247 -120 480 -231 399 352 306 420 372 321 272 221 170 121 30 -16 56 12 -28 -63 105 63 27 82 54 29 -6.3 -46 -82 -123 -161 -94
– – – – -6.9 -66 -66 -115 -154 -186 -231 -279 -334 -388 -455 -513 -578 -635 -695 -755 -812 -861 -917 -976 -1,032 -1,081 -1,124 -1,164 -1,212 -1,254 -1,205 -1,236 -1,269 -1,305 -1,343 -1,392 -1,439 -1,486 -1,469
– 9.2 9.2 9.2 25 25 25 25 25 36 60 61 61 62 67 72 73 74 75 75 76 76 77 91 94 95 95 193 225 226 239 226 227 227 227 2.8 2.8 2.9 4.1

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?